Acer Therapeutics Stock Price and Value Analysis

Should you buy Acer Therapeutics stock? (NasdaqCM:ACER). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantagesNeutral
  • This company has fluctuating growth.
  • This stock looks overpriced.
  • This company is not making money.
  • This company is less known than others.
  • This company pays no dividend.

Inside the ACER Numbers

ACER Price
(Acer Therapeutics stock price per share)
$3.06
[?] PE Ratio versus Sector 100% lower than other Healthcare stocks
[?] PE Ratio versus Industry 100% lower than other Biotechnology stocks
[?] Free Cash Flow Jitter 32%

Is Acer Therapeutics Stock on Sale?

Based on our analysis, we believe that you should not buy Acer Therapeutics right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy ACER Stock?

Does Acer Therapeutics have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.